Safingol/Fenretinide

N/A

Report date: 2025/04/29 16:58:17

Base Information

Drug NameSafingol/Fenretinide
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionApoptosis stimulantsRetinoic acid receptors agonistsProtein kinase C inhibitors
TargetsRetinoic acid receptorsProtein kinase C
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes SafingolFenretinide
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesCerrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesCerrx Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A